Compare · CJC-1295 + Ipamorelin vs NAD+
CJC-1295 + Ipamorelin vs NAD+
Researchers frequently look up CJC-1295 + Ipamorelin and NAD+ side by side. This reference compares the two as laboratory research materials, covering their chemistry, reported molecular targets, and the study areas each appears in. It does not rank them and makes no claim that either is preferable for any purpose; both are supplied strictly for research use.
At a glance
CJC-1295 + Ipamorelin is paired research peptides studied mainly in the context of growth-hormone-axis research and GH / IGF-1 secretion studies. NAD+ is research-grade coenzyme associated with cellular-metabolism research and longevity-pathway studies.
Both fall within Blueprint Labs' Performance & Longevity category, which is why they are often researched together or in sequence.
CJC-1295 + Ipamorelin: chemistry & targets
CJC-1295 No DAC + Ipamorelin is characterized in the literature by GHRH receptor (CJC-1295) and ghrelin / GHS-R1a receptor (Ipamorelin).
- Class
- paired research peptides
- Category
- Performance & Longevity
- Molecular weight
- 3367.97 g/mol (CJC-1295 No DAC) · 711.85 g/mol (Ipamorelin)
- CAS number
- 863288-34-0 (CJC-1295) · 170851-70-4 (Ipamorelin)
- Primary target
- GHRH receptor (CJC-1295)
- Physical form
- Two separate lyophilized vials
NAD+: chemistry & targets
β-Nicotinamide Adenine Dinucleotide (NAD+) is characterized in the literature by sirtuin (SIRT) activity, PARP-mediated DNA repair, and mitochondrial redox metabolism.
- Class
- research-grade coenzyme
- Category
- Performance & Longevity
- Molecular weight
- 663.43 g/mol
- CAS number
- 53-84-9
- Primary target
- sirtuin (SIRT) activity
- Physical form
- Lyophilized powder, research grade
How researchers choose between them
Selection in a research setting comes down to the model system and the question being asked: which molecular target is under study, which assays are planned, and how the compound is handled and reconstituted. This is a matter of experimental design, not of one compound being "better."
Both CJC-1295 + Ipamorelin and NAD+ are available from Blueprint Labs as third-party-tested research materials with certificates of analysis. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Available from Blueprint Labs
CJC 1295 No DAC + IPA 10mg
Both compounds are available from Blueprint Labs as third-party-tested research materials. CJC-1295 + Ipamorelin shown.
Questions, answered
What's the difference between CJC-1295 + Ipamorelin and NAD+?
They differ in chemistry and reported molecular targets: CJC-1295 + Ipamorelin is associated with GHRH receptor (CJC-1295), while NAD+ is associated with sirtuin (SIRT) activity. This page compares them only as research materials.
Are CJC-1295 + Ipamorelin and NAD+ studied together?
They share the Performance & Longevity research category and are sometimes referenced in adjacent literature, but any pairing is an experimental-design decision, not a recommendation.
Which one is better?
Neither is "better." They are distinct research compounds with different targets, and this reference makes no efficacy, safety, or suitability claim. For research use only. Not for human consumption, diagnostic, or therapeutic use.